Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma

被引:410
作者
Halazun, Karim J. [1 ]
Hardy, Mark A. [1 ]
Rana, Abbas A. [1 ]
Woodland, David C., III [1 ]
Luyten, Elijah J. [1 ]
Mahadev, Suhari [1 ]
Witkowski, Piotr [1 ]
Siegel, Abbey B. [1 ]
Brown, Robert S., Jr. [1 ]
Emond, Jean C. [1 ]
机构
[1] Columbia Univ, New York Presbyterian Hosp, Dept Organ Transplantat, New York, NY 10032 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; C-REACTIVE PROTEIN; CYCLOOXYGENASE-2 INHIBITOR ROFECOXIB; NEEDLE TRACT IMPLANTATION; COLORECTAL-CANCER; CURATIVE RESECTION; HEPATIC RESECTION; PREOPERATIVE NEUTROPHIL; CIRRHOTIC-PATIENTS; TUMOR RECURRENCE;
D O I
10.1097/SLA.0b013e3181a77e59
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The Milan criteria have been adopted by United Network for Organ Sharing (UNOS) to preoperatively assess outcome in patients will hepatocellular carcinoma (HCC) who receive orthotopic liver transplantation (OLT). These criteria rely solely on radiographic appearances of the tumor, providing no measure of tumor biology. Recurrence rates, therefore, remain around 20% for patients within the criteria. The neutrophil-lymphocyte ratio (NLR) is an indicator of inflammatory Status previously established as a prognostic indicator in colorectal liver metastases. We aimed to determine whether NLR predicts outcome in patients undergoing OLT for HCC. Design: Analysis of patients undergoing OLT for HCC between 2001 and 2007 at our institution. A NLR >= 5 was considered to be elevated. Results: A total of 150 patients were identified, with 13 patients having all elevated NLR. Of these, 62% developed recurrence compared with 14% with normal NLR (P < 0.0001). The disease-free survival for patients with high NLR was significantly worse than that for patients with normal NLR (1-, 3-, and 5-year survivals of 38%, 25%, and 25% vs. 92%, 85%, and 75%, P < 0.0001). Patients with high NLR also had poorer overall survival (5-year survival, 28% vs. 64%, P = 0.001). Patients within Milan with all elevated NLR had significantly poorer disease-free survival than those with normal NLR within Milan (5-year survival, 30% vs. 81%, P < 0.0001). On univariate analysis, 9 factors including all NLR >= 5 were significant predictors of poor disease-free survival. However, only a raised NLR remained significant on multivariate analysis (P = 0.005, HR: 19.98). Conclusion: Elevated NLR significantly increases the risk for tumor recurrence and recipient death. Preoperative NLR measurement may provide a simple method of identifying patients with poorer prognosis and act as an adjunct to Milan in determining, which patients benefit most from OLT.
引用
收藏
页码:141 / 151
页数:11
相关论文
共 58 条
  • [41] Navarro F, 1998, LIVER, V18, P251
  • [42] Lymphocytic infiltration surrounding liver metastases from colorectal cancer
    Okano, K
    Maeba, T
    Moroguchi, A
    Ishimura, K
    Karasawa, Y
    Izuishi, K
    Goda, F
    Usuki, H
    Wakabayashi, H
    Maeta, H
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2003, 82 (01) : 28 - 33
  • [43] Ries L., 2007, SEER CANC STAT REV 1
  • [44] SURGICAL-TREATMENT OF HEPATOCELLULAR-CARCINOMA - EXPERIENCE WITH LIVER RESECTION AND TRANSPLANTATION IN 198 PATIENTS
    RINGE, B
    PICHLMAYR, R
    WITTEKIND, C
    TUSCH, G
    [J]. WORLD JOURNAL OF SURGERY, 1991, 15 (02) : 270 - 285
  • [45] ROUSSEL F, 1989, ACTA CYTOL, V33, P937
  • [46] Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma
    Ryu, Soo Hyung
    Chung, Young-Hwa
    Lee, Hyunseung
    Kim, Jeong A.
    Shin, Hyun Deok
    Min, Hyun Joo
    Seo, Dong Dae
    Jang, Myoung Kuk
    Yu, Eunsil
    Kim, Kyu-Won
    [J]. HEPATOLOGY, 2008, 47 (03) : 929 - 936
  • [47] Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?
    Schwartz, M. E.
    D'Amico, F.
    Vitale, A.
    Emre, S.
    Cillo, U.
    [J]. EJSO, 2008, 34 (03): : 256 - 262
  • [48] Liver transplantation for hepatocellular carcinoma in cirrhosis:: Is clinical tumor classification before transplantation realistic?
    Sotiropoulos, GC
    Malagó, M
    Molmenti, E
    Paul, A
    Nadalin, S
    Brokalaki, E
    Kühl, H
    Dirsch, O
    Lang, H
    Broelsch, CE
    [J]. TRANSPLANTATION, 2005, 79 (04) : 483 - 487
  • [49] Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
    Sumie, Shuji
    Kuromatsu, Ryoko
    Okuda, Koji
    Ando, Eiji
    Takata, Akio
    Fukushima, Nobuyoshi
    Watanabe, Yasutomo
    Kojiro, Masamichi
    Sata, Michio
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (05) : 1375 - 1382
  • [50] Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
    Tanigawa, N
    Amaya, H
    Matsumura, M
    Shimomatsuya, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 826 - 832